Intercept Pharmaceuticals
ICPT
#6565
Rank
โ‚ฌ0.72 B
Marketcap
17,32ย โ‚ฌ
Share price
0.00%
Change (1 day)
-3.31%
Change (1 year)

EPS for Intercept Pharmaceuticals (ICPT)

EPS in 2023 (TTM): -1,37ย โ‚ฌ

According to Intercept Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -1,35ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 5,90ย โ‚ฌ an increase over its 2021 EPS that were of -2,63ย โ‚ฌ.

EPS history for Intercept Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,37ย โ‚ฌ-123.22%
20225,90ย โ‚ฌ-323.88%
2021-2,63ย โ‚ฌ-65.47%
2020-7,63ย โ‚ฌ-23.14%
2019-9,93ย โ‚ฌ-0.55%
2018-9,98ย โ‚ฌ-23.91%
2017-13,12ย โ‚ฌ-14.04%
2016-15,26ย โ‚ฌ76.4%
2015-8,65ย โ‚ฌ-33.78%
2014-13,06ย โ‚ฌ290.46%
2013-3,35ย โ‚ฌ-29.37%
2012-4,74ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
28,16ย โ‚ฌ-2,187.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,83ย โ‚ฌ 109.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-0,21ย โ‚ฌ-84.46%๐Ÿ‡บ๐Ÿ‡ธ USA